Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04854980 · ClinicalTrials.gov registry record
Serologic Response to the SARS-CoV-2 (COVID-19) MRNA-1273 Vaccine in Select Subsets of Oncology Patients
A clinical trial, sponsored by University of Rochester.
- Completed
- Registry status
- 8
- Enrollment target
NCT04854980 is a clinical trial that has completed, run by University of Rochester. The registered enrollment target is 8 participants.
The verdict
NCT04854980 has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- 8 participants
- Enrollment target
Study Summary
To explore the immune response to the COVID-19 vaccine in cancer patients and compare to the general population.
Interventions
- OTHER Blood Sample
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2021-08-03 |
| Est. Completion | 2024-07-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04854980
The ClinicalTrials.gov registry entry for NCT04854980 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Blood Sample is the first listed.
NCT04854980 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04854980 about?
NCT04854980 is a clinical study titled "Serologic Response to the SARS-CoV-2 (COVID-19) MRNA-1273 Vaccine in Select Subsets of Oncology Patients". To explore the immune response to the COVID-19 vaccine in cancer patients and compare to the general population.
What is the current status of trial NCT04854980?
This trial is currently completed. The enrollment target is 8 participants. The study started on 2021-08-03. Estimated completion is 2024-07-23.
What interventions are being tested in trial NCT04854980?
The interventions under investigation include: Blood Sample (OTHER).
Who is sponsoring clinical trial NCT04854980?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.